预印本 / 版本 2

Quantification of Glycan in Glycoproteins via AUCAgent-enhanced Analytical Ultracentrifugation

本文是预印本,尚未经过同行评审认证。

作者

    Xiaojuan Yu, 
    Xiaojuan Yu
    • National Institutes for Food and Drug Control
    Zhaoxing Wang, 
    Zhaoxing Wang
    Chengshi Zeng,  Ruifeng Zhang, 
    Ruifeng Zhang
    Qing Chang, 
    Qing Chang
    Wendan Chu, 
    Wendan Chu
    Qinghua Ma, 
    Qinghua Ma
    • Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd
    Ke Ma, 
    Ke Ma
    • Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd
    Lan Wang, 
    Lan Wang
    • National Institutes for Food and Drug Control
    Chuanfei Yu, 
    Chuanfei Yu
    Wenqi Li
    Wenqi Li
分类
关键词
Glycoprotein; Quantification; Analytical ultracentrifugation; AUCAgent

摘要

As essential biomolecules composed of proteins and carbohydrate moieties, glycoproteins play pivotal roles in numerous biological processes. The glycosylation level plays a crucial role in determining the functionality of glycoproteins. Therefore, the precise quantification of glycan components in proteins holds significant importance for research on and development of polysaccharide-protein-conjugated vaccines. In this study, a novel glycan quantification approach was developed, leveraging analytical ultracentrifugation (AUC) technology that synergistically utilizes ultraviolet wavelength absorption and interference data to directly determine glycan mass fractions in glycoproteins. This methodology expands the analytical framework for glycoproteins while retaining the intrinsic advantages of AUC, enabling analysis in native states with demonstrated robustness. The approach was implemented in our proprietary AUC data analysis software called AUCAgent.

指标

查看次数: 243
下载次数: 58

DOI:

Submission ID:

54

下载次数

已发布

2025-12-14

版本

如何引用

Yu, X., Wang, Z., Zeng, C., Zhang, R., Chang, Q., Chu, W., Ma, Q., Ma, K., Wang, L., Yu, C., & Li, W. (2025). Quantification of Glycan in Glycoproteins via AUCAgent-enhanced Analytical Ultracentrifugation. 浪淘沙预印本平台. https://doi.org/10.65215/j1ch6d86

利益冲突声明

作者声明无任何需要披露的利益冲突。